Barrons
10 Aug 2026, 11:23 UTC · 3h ago
This Biotech's Drug Could Treat Hot Flashes. The Stock Is Up 32% on Good News.
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Barrons
10 Aug 2026, 11:23 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
AbCellera's menopause treatment, ABCL635, demonstrated efficacy in reducing the frequency of hot flashes in patients after a single dose. — Positive clinical data for a new drug candidate typically drives upward valuation for the developing biotech company.
+0.60Which stocks this story touches
Positive clinical data showing the effectiveness of its menopause treatment ABCL635 in reducing hot flashes.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Continue reading
6 related stories
Search tags
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
6h ago
